Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
Supervisor：Ministry of Education of People’s Republic of ChinaSponsor：Sichuan University Editor-in-chief：Liu Lunxu Publishing period：
Monthly
ISSN：1007-4848CN：51-1492/R
Citation：生偉, 邢聰慧, 牛兆倬, 張文峰, 吳建濤, 李好友, 王天毅, 孫俊. “一站式”雜交技術在冠狀動脈多支血管病變中的臨床應用. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2020, 27(11): 1367-1370. doi: 10.7507/1007-4848.201912036Copy
Copyright ? the editorial department of Chinese Journal of Clinical Thoracic and Cardiovascular Surgery of West China Medical Publisher. All rights reserved
Kim DW, Her SH, Park HW, et al. Incremental age-related one-year MACCE after acute myocardial infarction in the drug-eluting stent era (from KAMIR-NIH registry). J Geriatr Cardiol, 2018, 15(9): 574-584.
3.
Fanari Z, Weiss SA, Zhang W, et al. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials. Cardiovasc Revasc Med, 2015, 16(2): 70-77.
4.
Hannan EL, Zhong Y, Walford G, et al. Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease. J Am Coll Cardiol, 2014, 64(25): 2717-2726.
Zhu P, Zhou P, Sun Y, et al. Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: systematic review and meta-analysis. J Cardiothorac Surg, 2015, 10: 63.
11.
Gierszewska K, Jaworska I, Skrzypek M, et al. Quality of life in patients with coronary artery disease treated with coronary artery bypass grafting and hybrid coronary revascularization. Cardiol J, 2018, 25(5): 621-627.
2. Kim DW, Her SH, Park HW, et al. Incremental age-related one-year MACCE after acute myocardial infarction in the drug-eluting stent era (from KAMIR-NIH registry). J Geriatr Cardiol, 2018, 15(9): 574-584.
3. Fanari Z, Weiss SA, Zhang W, et al. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials. Cardiovasc Revasc Med, 2015, 16(2): 70-77.
4. Hannan EL, Zhong Y, Walford G, et al. Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease. J Am Coll Cardiol, 2014, 64(25): 2717-2726.
7. Kayatta MO, Halkos ME, Puskas JD. Hybrid coronary revascularization for the treatment of multivessel coronary artery disease. Ann Cardiothorac Surg, 2018, 7(4): 500-505.
8. Sheng W, Yang HQ, Chi YF, et al. Independent risk factors for hypoxemia after surgery for acute aortic dissection. Saudi Med J, 2015, 36(8): 940-946.
10. Zhu P, Zhou P, Sun Y, et al. Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: systematic review and meta-analysis. J Cardiothorac Surg, 2015, 10: 63.
11. Gierszewska K, Jaworska I, Skrzypek M, et al. Quality of life in patients with coronary artery disease treated with coronary artery bypass grafting and hybrid coronary revascularization. Cardiol J, 2018, 25(5): 621-627.
1/5
WeChat